
@CathyTie has launched @OriginGenomics in New York to advance responsible germline gene correction for severe inherited diseases under IRB oversight. Following the conclusion of Manhattan Genomics, the company aims to push precision genome editing forward and explore MRT in the U.S., pending legislative approval, while keeping ethics and regulatory compliance at the center of genomic medicine. biospace.com/press-releases… Subscribe to our newsletter and get the biggest biotech news straight to your inbox 🧬. syntheticbiologysummit.com/signup?utm_sou…











